Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jun;20(6):1580-1584.
doi: 10.1111/jocd.14066. Epub 2021 Mar 21.

Oral candidiasis of COVID-19 patients: Case report and review of evidence

Abanoub Riad  1   2 , Esraa Gomaa  3 , Barbora Hockova  4 , Miloslav Klugar  1   2
Affiliations
Case Reports

Oral candidiasis of COVID-19 patients: Case report and review of evidence

Abanoub Riad et al. J Cosmet Dermatol. 2021 Jun.
No abstract available

Keywords: COVID-19; candidiasis; mouth mucosa; oral manifestations; tongue.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Oral candidiasis of COVID‐19 patients (Cairo, Egypt). (A) White membranous patches spread over the tongue dorsum, mouth floor, and soft palate of Case No. 1. (B) Erythematous candidiasis over the tongue dorsum of Case No. 2. (C) and (D) White membranous patches extended over the soft palate and labial mucosa, respectively
See this image and copyright information in PMC

References

    1. Iranmanesh B, Amiri R, Zartab H, Aflatoonian M. Oral manifestations of COVID‐19 disease: a review article. Dermatol Ther. 2020;34(1):e14578. 10.1111/dth.14578 - DOI - PMC - PubMed
    1. Riad A, Klugar M, Krsek M. COVID‐19‐related oral manifestations: early disease features? Oral Dis. 2020. 10.1111/odi.13516 - DOI - PMC - PubMed
    1. Hocková B, Riad A, Valky J, et al. Oral complications of ICU patients with COVID‐19: case‐series and review of two hundred ten cases. J Clin Med. 2021;10(4):581. 10.3390/jcm10040581 - DOI - PMC - PubMed
    1. Amorim dos Santos J, Normando AGC, Carvalho da Silva RL, et al. Oral mucosal lesions in a COVID‐19 patient: New signs or secondary manifestations? Int J Infect Dis. 2020;97:326‐328. 10.1016/j.ijid.2020.06.012 - DOI - PMC - PubMed
    1. Cantini F, Niccoli L, Matarrese D, Nicastri E, Stobbione P, Goletti D. Baricitinib therapy in COVID‐19: A pilot study on safety and clinical impact. J Infect. 2020;81(2):318‐356. 10.1016/j.jinf.2020.04.017 - DOI - PMC - PubMed